Invention Grant
- Patent Title: Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof
-
Application No.: US17288187Application Date: 2019-10-25
-
Publication No.: US11542332B2Publication Date: 2023-01-03
- Inventor: Jay M. Short , Gerhard Frey , Hwai Wen Chang
- Applicant: BioAtla, Inc.
- Applicant Address: US CA San Diego
- Assignee: BioAtla, Inc.
- Current Assignee: BioAtla, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Mendelsohn Dunleavy, P.C.
- International Application: PCT/US2019/058066 WO 20191025
- International Announcement: WO2020/092155 WO 20200507
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K47/68 ; A61P35/00
Abstract:
A polypeptide having a heavy chain variable region and/or light chain variable region that specifically binds to CTLA4 protein as well as antibodies and antibody fragments containing the heavy chain variable region and/or the light chain variable region that bind to CTLA4 protein. Pharmaceutical compositions and kits comprising the polypeptide or antibodies and antibody fragments containing the polypeptide are also provided.
Public/Granted literature
- US20210403565A1 ANTI-CTLA4 Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof Public/Granted day:2021-12-30
Information query
